Newest first
New topics page 22
Topics ordered by when they were created rather than by activity. This is where a question that nobody has answered yet is easiest to find — and answering one is the fastest route to a first solution badge.
1,535 topics · page 22 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
AOD-9604 and the fragment hypothesis, revisited — does this still hold?
The question in the title: AOD-9604 and the fragment hypothesis, revisited — does this still hold? I will give what I have already checked below so nobody repeats it. Comparing FLOW ( N Engl J Med , 2024)…
|
+7 | 11 | 31k | 19h |
|
A history of disordered eating: proceeding carefully
A history of disordered eating: proceeding carefully Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
|
+70 | 75 | 10k | 6mo |
|
Endotoxin and why it is a separate question from purity
Endotoxin and why it is a separate question from purity Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this number means before I repeat it…
|
2 | 22k | 4mo | |
|
Adsorptive losses at low concentration, and why dilute solutions are fragile
Adsorptive losses at low concentration, and why dilute solutions are fragile — setting out what I have, and where I think it stops being reliable. A question about technique rather than about dose. I have…
|
+16 | 20 | 1.7k | 4mo |
|
Severe gastroparesis and why this class is a poor fit — one year on
Severe gastroparesis and why this class is a poor fit — one year on — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published…
|
+19 | 23 | 23k | 7mo |
|
How to read a phase 2 result without treating it as a phase 3 result
The question in the title: How to read a phase 2 result without treating it as a phase 3 result I will give what I have already checked below so nobody repeats it. Session topic: FLOW ( N Engl J Med , 2024).…
|
+36 | 40 | 35k | 7mo |
|
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURMOUNT-OSA ( N Engl J Med ,…
|
+89 | 101 | 32k | 8mo |
|
Constipation management, with a dietitian's contribution
Posting this under the heading it deserves: Constipation management, with a dietitian's contribution Everything below is what sits behind that. Practical question with the units stated, because I have seen…
|
+79 | 88 | 27k | 21d |
|
Coming back to: Feature request: should a dose-equivalence tool exist at all?
Feature request: should a dose-equivalence tool exist at all? I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method first, because I know what the first…
|
+37 | 41 | 725 | 7mo |
|
Prescription requirements and telehealth models
Prescription requirements and telehealth models Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than anywhere…
|
+91 | 97 | 5.4k | 7mo |
|
[2026 update] What steady state means for the decision to escalate
The question in the title: What steady state means for the decision to escalate I will give what I have already checked below so nobody repeats it. I have read the maintained page on this and I still have a…
|
+127 | 137 | 32k | 8mo |
|
Dizziness on standing and the electrolyte explanation
On the subject in the title: Dizziness on standing and the electrolyte explanation Working notes rather than a conclusion. I have read the maintained page on this and I still have a gap, so I am asking rather…
|
+3 | 7 | 147 | 4mo |
|
Pre-registering a personal experiment, seriously — a second dataset
Posting this under the heading it deserves: Pre-registering a personal experiment, seriously — a second dataset Everything below is what sits behind that. I have seen STEP 8 ( JAMA , 2022) cited in support of…
|
+60 | 66 | 35k | 3mo |
|
Dose numbers for oral formulations are not comparable to injectable ones
On the subject in the title: Dose numbers for oral formulations are not comparable to injectable ones Working notes rather than a conclusion. Session topic: PIONEER 6 ( N Engl J Med , 2019). Please read it…
|
+19 | 23 | 39k | 6mo |
|
Second pass at: Why semaglutide's albumin binding is the whole reason weekly dosing works
Second pass at: Why semaglutide's albumin binding is the whole reason weekly dosing works Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURPASS-4 ( Lancet ,…
|
2 | 39k | 6mo | |
|
Whether protein timing matters at a large deficit
Posting this under the heading it deserves: Whether protein timing matters at a large deficit Everything below is what sits behind that. Longitudinal report with the method stated, because a number without a…
|
+29 | 33 | 7.7k | 4mo |
|
Micro-titration: a disputed topic, argued properly
Micro-titration: a disputed topic, argued properly Writing it up because I had to work it out twice and would rather nobody else did. A question about technique rather than about dose. I have been doing the…
|
+99 | 110 | 61k | 2d |
|
Search filters: what is missing
Search filters: what is missing — setting out what I have, and where I think it stops being reliable. Nominating something for promotion into the documentation commons. The topic in question keeps being…
|
+74 | 84 | 15k | 3d |
|
Long-time reader, first-time poster
On the subject in the title: Long-time reader, first-time poster Working notes rather than a conclusion. Lower-stakes topic, but the sourcing rule still applies if anyone makes a claim. Something adjacent…
|
+15 | 19 | 2.5k | 8mo |
|
About the Pens & autoinjectors category
Pen mechanics, dose counters, priming, and what happens when a pen is used off its label. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its…
|
+1 | 5 | 92 | 5mo |
|
Journal club: LEADER as the historical anchor
Journal club: LEADER as the historical anchor Writing it up because I had to work it out twice and would rather nobody else did. Comparing STEP 1 ( N Engl J Med , 2021) with SURMOUNT-4 ( JAMA , 2024) and…
|
+103 | 110 | 8.1k | 2h |
|
[2026 update] Currency conversion and the cost you did not see
Posting this under the heading it deserves: Currency conversion and the cost you did not see Everything below is what sits behind that. A logistics question, since the answers here are usually better than…
|
+21 | 26 | 52k | 2d |
|
Interpreting a result that disagrees with the supplier's certificate
Interpreting a result that disagrees with the supplier's certificate Writing it up because I had to work it out twice and would rather nobody else did. Structured report rather than an opinion, following the…
|
+129 | 153 | 7.3k | 5mo |
|
Second pass at: Metformin co-administration and additive GI effects
On the subject in the title: Second pass at: Metformin co-administration and additive GI effects Working notes rather than a conclusion. I have read the maintained page on this and I still have a gap, so I am…
|
+131 | 142 | 56k | 19d |
|
Shoulders, tangent skims, and defensible integration — the long version
Shoulders, tangent skims, and defensible integration — the long version Writing it up because I had to work it out twice and would rather nobody else did. Posting the method first, because I know what the…
|
+16 | 20 | 27k | 3mo |
|
When a dose reduction is the correct response to a side effect — a second dataset
When a dose reduction is the correct response to a side effect — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. I have read the maintained page on…
|
+10 | 14 | 42k | 2mo |
|
Conference abstracts as evidence: the weakest common citation
On the subject in the title: Conference abstracts as evidence: the weakest common citation Working notes rather than a conclusion. Session topic: SURMOUNT-1 ( N Engl J Med , 2022). Please read it before…
|
+1 | 5 | 2k | 9mo |
|
Citation sweep results: how many references did not say what was claimed
On the subject in the title: Citation sweep results: how many references did not say what was claimed Working notes rather than a conclusion. Process question about how this site works. I have read the…
|
+92 | 101 | 2.9k | 2mo |
|
The most useful thing you learned here that was not the answer you came for
The most useful thing you learned here that was not the answer you came for Writing it up because I had to work it out twice and would rather nobody else did. Lower-stakes topic, but the sourcing rule still…
|
+54 | 61 | 57k | 1d |
|
Reused chromatograms across lots: how to spot it
On the subject in the title: Reused chromatograms across lots: how to spot it Working notes rather than a conclusion. A documentation question rather than an analytical one. I have a certificate in front of…
|
+53 | 60 | 9.5k | 4h |